Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 231 to 240 of 2013

TitleReference numberPublishedLast updated
Bladder cancer: diagnosis and managementNG2
Blinatumomab for previously treated Philadelphia-chromosome-negative acute lymphoblastic leukaemiaTA450
Blinatumomab for previously treated Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal)TA686
Blinatumomab for treating acute lymphoblastic leukaemia in remission with minimal residual disease activityTA589
Blinatumomab with chemotherapy for consolidation treatment of Philadelphia-chromosome-negative CD19-positive minimal residual disease-negative B-cell precursor acute lymphoblastic leukaemiaTA1049
Blood transfusionNG24
Bone-anchored cystourethropexyHTG6
Borderline personality disorder: recognition and managementCG78
Bortezomib and thalidomide for the first‑line treatment of multiple myelomaTA228
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantationTA311

Results per page

  1. 10
  2. 25
  3. 50
  4. All